🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
120,26 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
149,50 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 3 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
14/12/2022 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
11/04/1989 10,40 10,50 10,36 10,50 +1,34% 1,34% 4.266.408
10/04/1989 10,40 10,42 10,32 10,36 -0,19% 0,96% 2.438.486
07/04/1989 10,46 10,46 10,36 10,38 -0,95% 0,95% 3.337.042
06/04/1989 10,42 10,54 10,38 10,48 +0,19% 1,53% 6.318.811
05/04/1989 10,48 10,50 10,30 10,46 +0,00% 1,90% 3.064.142
04/04/1989 10,36 10,48 10,36 10,46 +0,96% 1,15% 2.513.942
03/04/1989 10,32 10,42 10,28 10,36 +0,19% 1,35% 3.520.022
31/03/1989 10,36 10,42 10,26 10,34 -0,19% 1,54% 3.963.326
30/03/1989 10,40 10,42 10,32 10,36 -0,19% 0,96% 2.964.163
29/03/1989 10,38 10,44 10,30 10,38 +0,58% 1,34% 3.863.347
28/03/1989 10,32 10,34 10,28 10,32 +0,78% 0,58% 3.404.952
27/03/1989 10,16 10,28 10,10 10,24 +0,59% 1,76% 2.094.533
23/03/1989 10,30 10,42 10,14 10,18 -0,97% 2,70% 3.328.238
22/03/1989 10,24 10,30 10,16 10,28 +0,98% 1,36% 2.665.483
21/03/1989 10,20 10,26 10,14 10,18 +0,59% 1,17% 3.597.365
20/03/1989 10,20 10,20 10,04 10,12 -1,36% 1,56% 5.495.083
17/03/1989 10,26 10,32 10,12 10,26 -2,46% 1,94% 9.920.578
16/03/1989 10,32 10,54 10,28 10,52 +0,57% 2,50% 7.099.781
15/03/1989 10,54 10,58 10,44 10,46 -0,75% 1,32% 4.901.496
14/03/1989 10,54 10,54 10,44 10,54 +0,95% 0,94% 5.048.635
13/03/1989 10,28 10,50 10,26 10,44 +2,34% 2,32% 6.377.290
10/03/1989 10,26 10,26 10,06 10,20 -0,58% 1,94% 5.291.352
09/03/1989 10,34 10,38 10,24 10,26 -0,19% 1,35% 3.596.107
08/03/1989 10,16 10,38 10,10 10,28 +1,57% 2,74% 6.958.930
07/03/1989 10,18 10,22 10,12 10,12 -0,39% 0,98% 3.306.859
06/03/1989 10,24 10,24 10,16 10,16 +0,20% 0,78% 3.259.699
03/03/1989 10,22 10,26 10,10 10,14 -1,16% 1,56% 2.974.853
02/03/1989 10,02 10,26 10,00 10,26 +1,18% 2,58% 5.701.330
01/03/1989 10,18 10,24 10,04 10,14 -0,19% 1,95% 5.850.355
28/02/1989 9,98 10,18 9,96 10,16 +2,20% 2,19% 5.583.115